NCT00003944View on ClinicalTrials.gov

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

December 31, 1999

Study Completion Date

February 28, 2003

Conditions
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Interventions
BIOLOGICAL

filgrastim

DRUG

carboplatin

DRUG

cyclophosphamide

DRUG

paclitaxel

DRUG

topotecan hydrochloride

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

19111

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fox Chase Cancer Center

OTHER

NCT00003944 - Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter